LifeVantage Files Definitive Proxy Statement
SALT LAKE CITY, Sept. 25, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, filed its definitive proxy statement on September 22, 2023 with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its 2024 annual meeting of stockholders (the “Annual Meeting”), which is scheduled to be held on November 6, 2023. Stockholders as of the close of business on September 27, 2023 will be entitled to vote at the Annual Meeting.
- LifeVantage is continuing to execute on its LV360 plan—a plan that is working and is delivering value to all LifeVantage stockholders.
- The full text of the letter follows:
At this year’s annual meeting of stockholders (the “Annual Meeting”) of LifeVantage Corporation (“LifeVantage” or the “Company”) you will be faced with an important choice that we believe will determine the future of your investment in LifeVantage. - You can vote by following the instructions on the enclosed WHITE universal proxy card and promptly submitting your proxy by Internet or mail as described on the WHITE universal proxy card.
- One LifeVantage Community – Grow the community of those positively impacted by LifeVantage by entering new markets, growing existing markets and leaving a legacy of a better world for all.